Ayala Pharmaceuticals, Inc.
SEC CIK 1100397 · ADXS · last insider filing 2024-03-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Israel Biotech Fund I, L.P. | Director | filed 2023 - 2024 |
| Israel Biotech Fund II, L.P. | Director | filed 2023 - 2024 |
| I.B.F. Management Ltd. | Director | filed 2023 - 2024 |
| Israel Biotech Fund GP Partners, L.P. | Director | filed 2023 - 2024 |
| Israel Biotech Fund GP Partners II, L.P. | Director | filed 2023 - 2024 |
| Cabilly Yuval | Director | filed 2023 - 2023 |
| Martell Bridget A | Director | filed 2023 - 2023 |
| Orbach Pini | Director | filed 2023 - 2023 |
| Goldberg Murray A | Director | filed 2023 - 2023 |
| Sidransky David | Director | filed 2013 - 2023 |
| Spiegel Robert J. | Director | filed 2023 - 2023 |
| Bisker-Leib Vered | Director | filed 2023 - 2023 |
| Berman Richard J | Director | filed 2006 - 2020 |
| Appel Roni | Director | filed 2007 - 2020 |
| Patton James P | Director | filed 2006 - 2020 |
| Khleif Samir N | Director | filed 2014 - 2020 |
| Berlin Kenneth A | Director · President and CEO | filed 2018 - 2020 |
| Bonstein Sara | Director · Chief Financial Officer | filed 2014 - 2018 |
| Mckearn Thomas J | Director | filed 2006 - 2017 |
| Ridge Thomas J | Director | filed 2015 - 2017 |
| O'Connor Daniel J. | Director · SVP, Legal & Business Dev Off | filed 2013 - 2017 |
| Mayes, Gregory T. | Director · Chief Operating Officer | filed 2013 - 2017 |
| Moore Thomas A | Director · CHAIRMAN / CEO | filed 2006 - 2014 |
| Wade Martin R III | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Golan Roy | Chief Financial Officer | filed 2023 - 2023 |
| Gitelman Igor | Chief Accounting Officer | filed 2021 - 2021 |
| Henderson Molly | Executive Vice President & CFO | filed 2018 - 2020 |
| Gutierrez Andres | Executive Vice President & CMO | filed 2018 - 2020 |
| Petit Robert | Chief Scientific Officer | filed 2013 - 2018 |
| Lombardo Anthony A | Interim CEO | filed 2017 - 2018 |
| Mauro David J | Chief Medical Officer | filed 2014 - 2016 |
| French Christy LEE | VP-Regulatory, Medical Affairs | filed 2013 - 2015 |
| Rosenblum Mark J | Chief Financial Officer | filed 2010 - 2014 |
| Rothman John F | VP of Clinical Development | filed 2006 - 2011 |
| Cobb Fredrick D | Vice President of Finance | filed 2006 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.